CLINICAL_TRIALS
trial_result
· 2013-08-30
Clinical Trial Update: Safety and Pharmacokinetics Study of New Formulation of Bimatoprost in Patients With Alopecia [Phase 1]
Summary
Phase 1 safety and pharmacokinetics evaluation of a new formulation of bimatoprost in patients with alopecia. Results were posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Allergan | Conditions: Alopecia, Alopecia, Androgenetic | Phase 1 | Status: COMPLETED | Results posted: 2013-08-30